Cargando…
Extensive Study on Hematological, Immunological, Inflammatory Markers, and Biochemical Profile to Identify the Risk Factors in COVID-19 Patients
BACKGROUND: Tissue damage caused by COVID-19 could be detected by several clinical indicators including hematological, immunological, biochemical, and inflammatory markers. This study was to detect these clinical parameters to reveal the correlation between the factors and their roles in the develop...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200592/ https://www.ncbi.nlm.nih.gov/pubmed/35721343 http://dx.doi.org/10.1155/2022/5735546 |
_version_ | 1784728096892518400 |
---|---|
author | Ali, Eman T. Sajid Jabbar, Azza Al Ali, Hadeel S. Shaheen Hamadi, Saad Jabir, Majid S. Albukhaty, Salim |
author_facet | Ali, Eman T. Sajid Jabbar, Azza Al Ali, Hadeel S. Shaheen Hamadi, Saad Jabir, Majid S. Albukhaty, Salim |
author_sort | Ali, Eman T. |
collection | PubMed |
description | BACKGROUND: Tissue damage caused by COVID-19 could be detected by several clinical indicators including hematological, immunological, biochemical, and inflammatory markers. This study was to detect these clinical parameters to reveal the correlation between the factors and their roles in the development of COVID-19, to explore the hazard factors in severe cases. MATERIALS AND METHODS: A total of 200 participants of both sexes were included in the study, with an age range of (25–72) years, categorized into three main groups: 50 healthy individuals, 62 mild infected patients, and 88 severe infected patients with pneumonia. Different hematological and clinical parameters were included in the analysis (Basrah city, Iraq). Serum levels of interleukin-6 (IL-6), ferritin, and high-sensitivity C-reactive protein (hs-CRP) were assessed for all participants using an enzyme-linked immunosorbent assay (ELISA). The liver, renal, and cardiac functions were assessed by clinical chemistry testing. RESULTS: COVID-19 patients had leukocytosis, with an increased number of neutrophils and a decreased lymphocyte count, according to our findings. In regard to inflammatory parameters, both ESR and hs-CRP showed significant differences between the two groups, whereas IL-6 was significantly higher in the total severe group compared to the other two groups. Biochemical results revealed that each lactate dehydrogenase (LDH), ferritin, alanine aminotransferase (ALT), and aspartate aminotransferase (AST) had significant changes in the total severe group. Among pneumonic with an O2 requirement and pneumonic without an O2 requirement, there were significant differences in immunological and inflammatory markers (p > 0.05). The neutrophils-lymphocytes ratio (NLR) was highly elevated in severe who required O2. Moreover, IL-6, lymphocytes, and neutrophils were possible risk factors for COVID-19 infection, with the strongest influence of IL-6 with a high odds ratio (OR: 24.138, 95% CI: 8.437–30.65, p < 0.01). Furthermore, there were significant correlations among the indicators. CONCLUSION: Each of IL-6, lymphocytes, and neutrophils might represent major factors in the severity of COVID-19 and IL-6 plays the main role in inducing the inflammatory and pathophysiology process that is known as the cytokine storm. |
format | Online Article Text |
id | pubmed-9200592 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-92005922022-06-16 Extensive Study on Hematological, Immunological, Inflammatory Markers, and Biochemical Profile to Identify the Risk Factors in COVID-19 Patients Ali, Eman T. Sajid Jabbar, Azza Al Ali, Hadeel S. Shaheen Hamadi, Saad Jabir, Majid S. Albukhaty, Salim Int J Inflam Research Article BACKGROUND: Tissue damage caused by COVID-19 could be detected by several clinical indicators including hematological, immunological, biochemical, and inflammatory markers. This study was to detect these clinical parameters to reveal the correlation between the factors and their roles in the development of COVID-19, to explore the hazard factors in severe cases. MATERIALS AND METHODS: A total of 200 participants of both sexes were included in the study, with an age range of (25–72) years, categorized into three main groups: 50 healthy individuals, 62 mild infected patients, and 88 severe infected patients with pneumonia. Different hematological and clinical parameters were included in the analysis (Basrah city, Iraq). Serum levels of interleukin-6 (IL-6), ferritin, and high-sensitivity C-reactive protein (hs-CRP) were assessed for all participants using an enzyme-linked immunosorbent assay (ELISA). The liver, renal, and cardiac functions were assessed by clinical chemistry testing. RESULTS: COVID-19 patients had leukocytosis, with an increased number of neutrophils and a decreased lymphocyte count, according to our findings. In regard to inflammatory parameters, both ESR and hs-CRP showed significant differences between the two groups, whereas IL-6 was significantly higher in the total severe group compared to the other two groups. Biochemical results revealed that each lactate dehydrogenase (LDH), ferritin, alanine aminotransferase (ALT), and aspartate aminotransferase (AST) had significant changes in the total severe group. Among pneumonic with an O2 requirement and pneumonic without an O2 requirement, there were significant differences in immunological and inflammatory markers (p > 0.05). The neutrophils-lymphocytes ratio (NLR) was highly elevated in severe who required O2. Moreover, IL-6, lymphocytes, and neutrophils were possible risk factors for COVID-19 infection, with the strongest influence of IL-6 with a high odds ratio (OR: 24.138, 95% CI: 8.437–30.65, p < 0.01). Furthermore, there were significant correlations among the indicators. CONCLUSION: Each of IL-6, lymphocytes, and neutrophils might represent major factors in the severity of COVID-19 and IL-6 plays the main role in inducing the inflammatory and pathophysiology process that is known as the cytokine storm. Hindawi 2022-04-21 /pmc/articles/PMC9200592/ /pubmed/35721343 http://dx.doi.org/10.1155/2022/5735546 Text en Copyright © 2022 Eman T. Ali et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Ali, Eman T. Sajid Jabbar, Azza Al Ali, Hadeel S. Shaheen Hamadi, Saad Jabir, Majid S. Albukhaty, Salim Extensive Study on Hematological, Immunological, Inflammatory Markers, and Biochemical Profile to Identify the Risk Factors in COVID-19 Patients |
title | Extensive Study on Hematological, Immunological, Inflammatory Markers, and Biochemical Profile to Identify the Risk Factors in COVID-19 Patients |
title_full | Extensive Study on Hematological, Immunological, Inflammatory Markers, and Biochemical Profile to Identify the Risk Factors in COVID-19 Patients |
title_fullStr | Extensive Study on Hematological, Immunological, Inflammatory Markers, and Biochemical Profile to Identify the Risk Factors in COVID-19 Patients |
title_full_unstemmed | Extensive Study on Hematological, Immunological, Inflammatory Markers, and Biochemical Profile to Identify the Risk Factors in COVID-19 Patients |
title_short | Extensive Study on Hematological, Immunological, Inflammatory Markers, and Biochemical Profile to Identify the Risk Factors in COVID-19 Patients |
title_sort | extensive study on hematological, immunological, inflammatory markers, and biochemical profile to identify the risk factors in covid-19 patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200592/ https://www.ncbi.nlm.nih.gov/pubmed/35721343 http://dx.doi.org/10.1155/2022/5735546 |
work_keys_str_mv | AT aliemant extensivestudyonhematologicalimmunologicalinflammatorymarkersandbiochemicalprofiletoidentifytheriskfactorsincovid19patients AT sajidjabbarazza extensivestudyonhematologicalimmunologicalinflammatorymarkersandbiochemicalprofiletoidentifytheriskfactorsincovid19patients AT alalihadeels extensivestudyonhematologicalimmunologicalinflammatorymarkersandbiochemicalprofiletoidentifytheriskfactorsincovid19patients AT shaheenhamadisaad extensivestudyonhematologicalimmunologicalinflammatorymarkersandbiochemicalprofiletoidentifytheriskfactorsincovid19patients AT jabirmajids extensivestudyonhematologicalimmunologicalinflammatorymarkersandbiochemicalprofiletoidentifytheriskfactorsincovid19patients AT albukhatysalim extensivestudyonhematologicalimmunologicalinflammatorymarkersandbiochemicalprofiletoidentifytheriskfactorsincovid19patients |